Target intelligence / Profile preview

Ribosomal protein S6 pseudogene 23 (RPS6P23)

Target
RPS6P23
Molecular classification
Other, Pseudogene
01

Overview

Ribosomal protein S6 pseudogene 23 (RPS6P23) is a genomic DNA sequence in humans that resembles the functional gene for ribosomal protein S6 but is classified as a pseudogene, meaning it does not encode a functional protein. Pseudogenes such as RPS6P23 arise mainly due to duplication or retrotransposition events and typically accumulate mutations which prevent them from producing active proteins. While *some* pseudogenes have been implicated in gene regulation (through mechanisms like serving as miRNA decoys or producing noncoding RNAs), there is currently **no evidence that RPS6P23 has a known biological function, disease relevance, or role as a drug target**. RPS6P23 is not a receptor, enzyme, transporter, or any typical drug target—it is a processed pseudogene related to ribosomal protein S6, which itself is an essential component of the 40S ribosomal subunit. Pseudogenes occasionally play indirect regulatory roles in gene expression but are not considered canonical drug or therapeutic targets. There are no drugs known to interact with RPS6P23, and it is not considered a biomarker for any disease. Its status as a pseudogene and lack of coding capacity mean it generally falls outside the scope of conventional molecular target classification.

Other names
RPS6P23
02

Biological functions

Other (no direct function, as it is a pseudogene)
03

Disease associations

Other (no direct disease role established; general pseudogene regulatory roles possible)

Beyond the preview

Go deeper on Ribosomal protein S6 pseudogene 23 (RPS6P23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S6 pseudogene 23 (RPS6P23).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call